4//SEC Filing
EPIRUS Biopharmaceuticals, Inc. 4
Accession 0001104659-16-124526
CIK 0001135906operating
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:51 PM ET
Size
6.6 KB
Accession
0001104659-16-124526
Insider Transaction Report
Form 4
Wyand Michael
See Remarks
Transactions
- Award
Restricted Stock Units
2016-05-27+280,000→ 280,000 total→ Common Stock (280,000 underlying)
Footnotes (2)
- [F1]Represents an award of restricted stock units ("RSUs"), each of which represents a contingent right to receive a share of the Issuer's common stock and has no expiration date. The award will vest over two years according to the following vesting schedule: (i) if a sale of the Issuer's B0W15 program occurs on or before May 27, 2017, then (a) 40% of the RSUs will vest on the date of such sale (the "Sale Date"), (b) 30% of the RSUs will vest on May 27, 2017 and (c) 30% of the RSUs will vest on May 27, 2018, and (ii) if the Sale Date does not occur on or prior to May 27, 2017, then (a) 50% of the RSUs will vest on May 27, 2017 and (b) 50% of the RSUs will vest on May 27, 2018; in any event provided the Reporting Person remains continuously employed by the Issuer through each vesting date.
- [F2]The vesting of any unvested portion of the award will be immediately accelerated if the Reporting Person's employment is terminated without cause, other than due to the Reporting Person's voluntary resignation, prior to the award being fully vested.
Documents
Issuer
EPIRUS Biopharmaceuticals, Inc.
CIK 0001135906
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001135906
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:51 PM ET
- Size
- 6.6 KB